Introduction:
This quiz collection titled Introduction to Pharmacokinetics and Toxicokinetics MCQs With Answer is designed for M.Pharm students studying Modern Bio-Analytical Techniques (MPA 202T). The set focuses on core PK/TK concepts — absorption, distribution, metabolism, excretion, compartmental models, clearance, volume of distribution, half-life, bioavailability, and toxicokinetic dose metrics — and links these concepts to bioanalytical considerations such as sampling matrix, assay sensitivity and unbound drug measurements. Each question challenges conceptual understanding and practical interpretation of PK/TK data commonly encountered in preclinical and clinical bioanalysis, helping students prepare for exams and applied laboratory work.
Q1. Which statement best defines pharmacokinetics?
- The study of drug effects and mechanisms at target receptors
- The quantitative study of drug absorption, distribution, metabolism and excretion over time
- The assessment of adverse drug reactions in populations
- The design of dosage forms to improve patient adherence
Correct Answer: The quantitative study of drug absorption, distribution, metabolism and excretion over time
Q2. Absolute bioavailability (F) is most directly estimated by which ratio?
- AUCpo / AUCiv
- (AUCpo × Doseiv) / (AUCiv × Dosepo)
- Cmax_po / Cmax_iv
- (Tmax_po) / (Tmax_iv)
Correct Answer: (AUCpo × Doseiv) / (AUCiv × Dosepo)
Q3. Volume of distribution (Vd) primarily indicates:
- The total amount of drug eliminated per unit time
- The theoretical volume required to contain the total drug amount at the measured plasma concentration
- The fraction of drug bound to plasma proteins
- The bioavailability after oral dosing
Correct Answer: The theoretical volume required to contain the total drug amount at the measured plasma concentration
Q4. Clearance (CL) is best described as:
- The half-life multiplied by the volume of distribution
- The volume of plasma from which the drug is completely removed per unit time
- The fraction of drug absorbed from the gastrointestinal tract
- The maximum rate of drug metabolism under saturation
Correct Answer: The volume of plasma from which the drug is completely removed per unit time
Q5. The elimination half-life (t1/2) in a one-compartment linear system is related to clearance and volume of distribution by which expression?
- t1/2 = CL / (0.693 × V)
- t1/2 = 0.693 × V / CL
- t1/2 = V × CL
- t1/2 = 1 / (CL × V)
Correct Answer: t1/2 = 0.693 × V / CL
Q6. A fundamental assumption of a one-compartment model is:
- The body consists of two kinetically distinct compartments with rapid equilibrium
- The drug distributes instantaneously and uniformly throughout a single, well-mixed compartment
- Elimination occurs only from a peripheral compartment
- Absorption rate is always slower than elimination rate
Correct Answer: The drug distributes instantaneously and uniformly throughout a single, well-mixed compartment
Q7. Nonlinear pharmacokinetics often results from which mechanism?
- First-order renal clearance independent of dose
- Capacity-limited metabolism described by Michaelis–Menten kinetics
- Instantaneous and unlimited tissue binding
- Complete and constant oral bioavailability
Correct Answer: Capacity-limited metabolism described by Michaelis–Menten kinetics
Q8. Hepatic extraction ratio (EH) is defined as:
- EH = Ce / Ca where Ce is hepatic effluent concentration
- EH = (Ca – Cv) / Ca where Ca is arterial and Cv is hepatic venous concentration
- EH = CLrenal / CLtotal
- EH = Tmax / Cmax
Correct Answer: EH = (Ca – Cv) / Ca where Ca is arterial and Cv is hepatic venous concentration
Q9. In therapeutic drug monitoring, why is measuring unbound (free) drug concentration often more informative than total drug concentration?
- Unbound concentration is less affected by sampling time
- Only unbound drug is pharmacologically active and available for clearance and tissue distribution
- Total concentration is always proportional to unbound concentration regardless of binding changes
- Unbound concentration is easier to measure analytically
Correct Answer: Only unbound drug is pharmacologically active and available for clearance and tissue distribution
Q10. After repeated dosing at fixed intervals, steady state is typically achieved after approximately how many half-lives?
- 1 half-life
- 2 half-lives
- 4–5 half-lives
- 10–12 half-lives
Correct Answer: 4–5 half-lives
Q11. Area under the plasma concentration-time curve (AUC) most directly reflects which of the following?
- Rate of absorption only
- Total systemic exposure to the drug over time
- Maximum effect at the target site
- Volume of distribution
Correct Answer: Total systemic exposure to the drug over time
Q12. Noncompartmental analysis (NCA) typically estimates pharmacokinetic parameters using which approach?
- Solving differential equations for compartment models
- Statistical moment theory and the trapezoidal rule to estimate AUC and related parameters
- Assuming infinite clearance to simplify calculations
- Relying solely on peak concentrations without time integration
Correct Answer: Statistical moment theory and the trapezoidal rule to estimate AUC and related parameters
Q13. Which sampling matrix is most commonly used for human pharmacokinetic studies to assess systemic exposure?
- Urine only
- Faeces only
- Plasma or serum
- Tissue biopsy samples from the target organ
Correct Answer: Plasma or serum
Q14. For a drug that exhibits concentration-dependent toxicity related to peak exposure, which pharmacokinetic metric is most predictive of toxicity?
- AUC over dosing interval
- Cmax
- Trough concentration (Cmin)
- Apparent volume of distribution
Correct Answer: Cmax
Q15. Which of the following statements regarding first-pass metabolism is correct?
- First-pass metabolism increases absolute bioavailability
- It refers to presystemic elimination in the gut wall and liver that can substantially reduce oral bioavailability
- It only occurs after intravenous dosing
- It is independent of hepatic blood flow and enzyme activity
Correct Answer: It refers to presystemic elimination in the gut wall and liver that can substantially reduce oral bioavailability
Q16. In linear (dose-proportional) pharmacokinetics, which parameter remains constant across different doses?
- Clearance (CL)
- Cmax/Dose ratio
- Half-life only at very high doses
- Vmax of metabolism
Correct Answer: Clearance (CL)
Q17. Which bioanalytical consideration is most critical when interpreting PK data for a highly protein-bound drug?
- Only total concentration is relevant; unbound fraction can be ignored
- Measurement of unbound concentration or accurate determination of unbound fraction to relate measured concentrations to pharmacologic effect
- Assume unbound fraction is constant across disease states and drug interactions
- Tissue binding replaces the need to assess plasma protein binding
Correct Answer: Measurement of unbound concentration or accurate determination of unbound fraction to relate measured concentrations to pharmacologic effect
Q18. Which statement correctly describes toxicokinetics (TK) in safety assessment?
- Toxicokinetics ignores dose–exposure relationships and focuses only on clinical signs
- TK characterizes internal exposure (e.g., AUC, Cmax) after toxicology dosing to link dose to systemic exposure and potential toxicity
- Toxicokinetics only applies to inhalation exposures
- Toxicokinetics replaces the need for pharmacodynamic evaluation in toxicology studies
Correct Answer: TK characterizes internal exposure (e.g., AUC, Cmax) after toxicology dosing to link dose to systemic exposure and potential toxicity
Q19. Which dosing strategy will increase accumulation of a drug between doses?
- Using a dosing interval much longer than the elimination half-life
- Shortening the dosing interval relative to the elimination half-life
- Decreasing the dose while keeping the same interval
- Switching from oral to intravenous administration without changing dose or interval
Correct Answer: Shortening the dosing interval relative to the elimination half-life
Q20. Advantages of microsampling techniques (e.g., dried blood spots, capillary microsampling) in PK/TK studies include:
- Increased blood volume requirement and reduced sampling frequency
- Lower assay sensitivity and greater matrix effects compared with large-volume plasma samples
- Reduced animal and patient blood loss, enabling richer time profiles and serial sampling in small subjects
- Elimination of the need for method validation
Correct Answer: Reduced animal and patient blood loss, enabling richer time profiles and serial sampling in small subjects
